Literature DB >> 25572532

The osteopontin transgenic mouse is a new model for Sjögren's syndrome.

Sehba Husain-Krautter1, Jill M Kramer2, Wentian Li3, Benchang Guo4, Thomas L Rothstein5.   

Abstract

Osteopontin (Opn) is a cytokine involved in both physiological and pathological processes, and is elevated in many autoimmune diseases. Sjögren's syndrome (SS) is an autoimmune disease with a strong female predilection characterized by lymphocytic infiltration of exocrine glands. We hypothesized that Opn contributes to SS pathogenesis. We examined an established SS model and found increased Opn locally and systemically. Next, we examined Opn transgenic (Opn Tg) mice for evidence of SS. Opn Tg animals exhibited lymphocytic infiltration of salivary and lacrimal glands, and Opn co-localized with the infiltrates. Moreover, saliva production was reduced, and SS autoantibodies were observed in the serum of these mice. Finally, female Opn Tg mice showed more severe disease compared to males. Taken together, these data support a role for Opn in SS pathogenesis. We identify a new model of spontaneous SS that recapitulates the human disease in terms of sex predilection, histopathology, salivary deficits, and autoantibodies.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B cell; Osteopontin; Sialadenitis; Sjogren's syndrome

Mesh:

Substances:

Year:  2015        PMID: 25572532      PMCID: PMC4357545          DOI: 10.1016/j.clim.2014.12.010

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  80 in total

1.  Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis.

Authors:  Gikas E Katsifis; Sofia Rekka; Niki M Moutsopoulos; Stanley Pillemer; Sharon M Wahl
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

2.  B cell receptor crosstalk: B cells express osteopontin through the combined action of the alternate and classical BCR signaling pathways.

Authors:  Benchang Guo; Joseph R Tumang; Thomas L Rothstein
Journal:  Mol Immunol       Date:  2008-10-25       Impact factor: 4.407

Review 3.  Osteopontin: role in immune regulation and stress responses.

Authors:  Kathryn X Wang; David T Denhardt
Journal:  Cytokine Growth Factor Rev       Date:  2008-10-25       Impact factor: 7.638

4.  Specifically modified osteopontin in rheumatoid arthritis fibroblast-like synoviocytes supports interaction with B cells and enhances production of interleukin-6.

Authors:  Yasuhiro Take; Ken Nakata; Jun Hashimoto; Hideki Tsuboi; Norihiro Nishimoto; Takahiro Ochi; Hideki Yoshikawa
Journal:  Arthritis Rheum       Date:  2009-12

5.  Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study.

Authors:  S Dass; S J Bowman; E M Vital; K Ikeda; C T Pease; J Hamburger; A Richards; S Rauz; P Emery
Journal:  Ann Rheum Dis       Date:  2008-02-14       Impact factor: 19.103

6.  Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells.

Authors:  Kexing Fan; Jianxin Dai; Hao Wang; Huafeng Wei; Zhiguo Cao; Sheng Hou; Weizhu Qian; Huaqing Wang; Bohua Li; Jian Zhao; Huji Xu; Chengde Yang; Yajun Guo
Journal:  Arthritis Rheum       Date:  2008-07

7.  Osteopontin promotes the development of natural killer cells from hematopoietic stem cells.

Authors:  Jin Woong Chung; Mi Sun Kim; Zheng-Hao Piao; Mira Jeong; Suk Ran Yoon; Nara Shin; Sang Yong Kim; Eun Sook Hwang; Young Yang; Young Ho Lee; Young Sang Kim; Inpyo Choi
Journal:  Stem Cells       Date:  2008-06-05       Impact factor: 6.277

8.  Association of alleles at polymorphic sites in the Osteopontin encoding gene in young type 1 diabetic patients.

Authors:  Renato Marciano; Giuseppe D'Annunzio; Nicola Minuto; Lorenzo Pasquali; Andrea Santamaria; Marco Di Duca; Roberto Ravazzolo; Renata Lorini
Journal:  Clin Immunol       Date:  2009-01-12       Impact factor: 3.969

9.  Osteopontin regulates development and function of invariant natural killer T cells.

Authors:  Hongyan Diao; Kazuya Iwabuchi; Lanjuan Li; Kazunori Onoe; Luc Van Kaer; Shigeyuki Kon; Yoshinari Saito; Junko Morimoto; David T Denhardt; Susan Rittling; Toshimitsu Uede
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-03       Impact factor: 11.205

10.  Hypoxia skews dendritic cells to a T helper type 2-stimulating phenotype and promotes tumour cell migration by dendritic cell-derived osteopontin.

Authors:  Meixiang Yang; Chunhong Ma; Shuxun Liu; Jintang Sun; Qianqian Shao; Wenjuan Gao; Yan Zhang; Zewu Li; Qi Xie; Zhaogang Dong; Xun Qu
Journal:  Immunology       Date:  2008-10-21       Impact factor: 7.397

View more
  9 in total

Review 1.  Studying Sjögren's syndrome in mice: What is the best available model?

Authors:  Ghada Abughanam; Ola M Maria; Simon D Tran
Journal:  J Oral Biol Craniofac Res       Date:  2020-12-08

Review 2.  Osteopontin in autoimmune disorders: current knowledge and future perspective.

Authors:  Canhua Xu; Yaohong Wu; Ning Liu
Journal:  Inflammopharmacology       Date:  2022-03-02       Impact factor: 5.093

Review 3.  Osteopontin in Immune-mediated Diseases.

Authors:  S R Rittling; R Singh
Journal:  J Dent Res       Date:  2015-09-04       Impact factor: 6.116

4.  Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes.

Authors:  Samantha S Soldan; Chenhe Su; R Jason Lamontagne; Nicholas Grams; Fang Lu; Yue Zhang; James D Gesualdi; Drew M Frase; Lois E Tolvinski; Kayla Martin; Troy E Messick; Jonathan T Fingerut; Ekaterina Koltsova; Andrew Kossenkov; Paul M Lieberman
Journal:  PLoS Pathog       Date:  2021-06-09       Impact factor: 6.823

Review 5.  Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases.

Authors:  Nausicaa Clemente; Davide Raineri; Giuseppe Cappellano; Elena Boggio; Francesco Favero; Maria Felicia Soluri; Chiara Dianzani; Cristoforo Comi; Umberto Dianzani; Annalisa Chiocchetti
Journal:  J Immunol Res       Date:  2016-12-20       Impact factor: 4.818

Review 6.  Contribution of HIV Infection, AIDS, and Antiretroviral Therapy to Exocrine Pathogenesis in Salivary and Lacrimal Glands.

Authors:  Imran Nizamuddin; Peter Koulen; Carole P McArthur
Journal:  Int J Mol Sci       Date:  2018-09-13       Impact factor: 5.923

7.  Chemokines Up-Regulated in Epithelial Cells Control Senescence-Associated T Cell Accumulation in Salivary Glands of Aged and Sjögren's Syndrome Model Mice.

Authors:  Mie Kurosawa; Yosuke Shikama; Masae Furukawa; Rieko Arakaki; Naozumi Ishimaru; Kenji Matsushita
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

8.  Advances in Pathogenesis of Sjögren's Syndrome.

Authors:  Yao Tian; Hongyi Yang; Na Liu; Yan Li; Jie Chen
Journal:  J Immunol Res       Date:  2021-10-07       Impact factor: 4.818

9.  Osteopontin and malaria: no direct effect on parasite growth, but correlation with P. falciparum-specific B cells and BAFF in a malaria endemic area.

Authors:  Susanne E Mortazavi; Allan Lugaajju; Mark Kaddumukasa; Muyideen Kolapo Tijani; Fred Kironde; Kristina E M Persson
Journal:  BMC Microbiol       Date:  2021-11-06       Impact factor: 3.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.